Cathie Wood’s ARK Invest Buys Over 330,000 Shares of CM Life Sciences

One of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 330,000 shares of CM Life Sciences Inc. (NASDAQ: CMLF) shares altogether on Wednesday, as the price of this ETF was up around 1.7% in Wednesday’s session. This fund is up a fair amount in the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 332,385 shares of CM Life Sciences. At Wednesday’s closing price, this would have valued this purchase at roughly $4.3 million. This is only a small fraction of the total holdings. ARKG is up 76% in the past 52 weeks.

Check out all of ARK Invest’s buys for Wednesday:

FundTickerCompanyShares
ARKF4689JPZ HOLDINGS CORP566,500
ARKFKSPILIKASPI.KZ JSC3,588
ARKGRPTXREPARE THERAPEUTICS INC22,480
ARKGMASS908 DEVICES INC31,772
ARKGDRNADICERNA PHARMACEUTICALS INC700
ARKGCMLFCM LIFE SCIENCES INC332,385
ARKGCMIIUCM LIFE SCIENCES II INC37,200
ARKGCDXSCODEXIS INC200
ARKQSPFRJAWS SPITFIRE ACQUISITION CORP29,301
ARKQIRDMIRIDIUM COMMUNICATIONS INC68,102
ARKQAONEONE103,849
ARKQACICATLAS CREST INVESTMENT CORP76,072
ARKWVUZIVUZIX CORP20,630
ARKXUUNITY SOFTWARE INC2,936
ARKXBLDEBLADE AIR MOBILITY INC7,817

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.

ALSO READ: 5 High-Yielding Dividend Aristocrats May Be the Best Stocks to Own Now


Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article